Northern Kentucky Center for Pain Relief, LLC
Northern Kentucky Center for Pain Relief, LLC was paid $4.86M by Medicaid between Jan 2018 and Oct 2022, across 27 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 41% of everything it billed.
FLORENCE, KY 41042
Next to other Pain Medicine (Anesthesiology) Physician providers in Kentucky
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,967 | $1.76M | |
| 2019 | 32,531 | $1.51M | |
| 2020 | 27,637 | $1.22M | |
| 2021 | 12,677 | $354K | |
| 2022 | 2,158 | $14K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 41% | 13,567 | 10,913 | $2.01M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 20% | 24,479 | 18,269 | $962K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 12% | 6,019 | 3,785 | $563K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.2% | 11,108 | 9,074 | $398K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.8% | 12,698 | 8,550 | $282K |
| L0650 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf | 2.8% | 171 | 139 | $135K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 7,805 | 3,724 | $95K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 1.8% | 6,039 | 2,824 | $89K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.3% | 7,867 | 3,754 | $63K |
| 97012 | 1.2% | 7,744 | 3,658 | $57K | |
| 97014 | 1.0% | 7,140 | 3,514 | $50K | |
| 98940 | <1% | 2,110 | 1,071 | $25K |
15 more codes
| 84311 | <1% | 4,143 | $24K | |
| 62323 | <1% | 224 | $22K | |
| 82570 | <1% | 4,135 | $18K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 225 | $14K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 773 | $9K |
| 95923 | <1% | 107 | $9K | |
| 95924 | <1% | 102 | $8K | |
| 93923 | <1% | 121 | $8K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 107 | $5K |
| 99442 | <1% | 301 | $4K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 101 | $3K |
| 20610 | <1% | 68 | $2K | |
| 81003 | <1% | 2,397 | $339.01 | |
| 72100 | <1% | 13 | $263.56 | |
| G0281 | Electrical stimulation, (unattended), to one or more areas, for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care | 0% | 406 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.